Your browser doesn't support javascript.
loading
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy.
Tanaka, Yosuke; Aoyagi, Kazuhiko; Minashi, Keiko; Komatsuzaki, Rie; Komatsu, Masayuki; Chiwaki, Fumiko; Tamaoki, Masashi; Nishimura, Takao; Takahashi, Naoki; Oda, Ichiro; Tachimori, Yuji; Arao, Tokuzo; Nishio, Kazuto; Kitano, Shigehisa; Narumi, Kenta; Aoki, Kazunori; Fujii, Satoshi; Ochiai, Atsushi; Yoshida, Teruhiko; Muto, Manabu; Yamada, Yasuhide; Sasaki, Hiroki.
Afiliação
  • Tanaka Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Aoyagi K; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Minashi K; Department of Clinical Trial Promotion, Chiba Cancer Center, Chiba, Japan.
  • Komatsuzaki R; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Komatsu M; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Chiwaki F; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Tamaoki M; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Nishimura T; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Takahashi N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Oda I; Department of Gastrointestinal Oncology and Endoscopy, National Cancer Center Hospital, Tokyo, Japan.
  • Tachimori Y; Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Arao T; Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan.
  • Nishio K; Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan.
  • Kitano S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Narumi K; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  • Aoki K; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  • Fujii S; Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, Tokyo, Japan.
  • Ochiai A; Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, Tokyo, Japan.
  • Yoshida T; Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
  • Muto M; Department of Therapeutic Oncology, Kyoto University, Kyoto, Japan.
  • Yamada Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Sasaki H; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan.
PLoS One ; 10(12): e0143804, 2015.
Article em En | MEDLINE | ID: mdl-26625258
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Linfócitos T Citotóxicos / Quimiorradioterapia Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Linfócitos T Citotóxicos / Quimiorradioterapia Idioma: En Ano de publicação: 2015 Tipo de documento: Article